Articles published by Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
November 15, 2024
Via GlobeNewswire
Tickers
CRNX
Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 12, 2024
Via GlobeNewswire
Tickers
CRNX
Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 11, 2024
Via GlobeNewswire
Tickers
CRNX
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
October 16, 2024
Via GlobeNewswire
Tickers
CRNX
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
October 08, 2024
Via GlobeNewswire
Tickers
CRNX
Via GlobeNewswire
Tickers
CRNX
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
September 26, 2024
Via GlobeNewswire
Tickers
CRNX
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 10, 2024
Via GlobeNewswire
Tickers
CRNX
Via GlobeNewswire
Tickers
CRNX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.